To the Editor: We report on a patient with type 1 diabetes mellitus,diagnosed at 16 years of age, in whom widespread amyloid depositsdeveloped many years later in transplanted human islets. Theislets were administered through three intraportal infusions:two infusions were administered 4 months apart when the patientwas 50 years of age, and one infusion was administered whenhe was 54 years of age.
Before the first implantation, the treatment of the patient,who had a functioning renal transplant, was switched to theEdmonton immunosuppression protocol (i.e., daclizumab, tacrolimus,and sirolimus). After the second islet transplantation, the. . . [Full Text of this Article]
Related Letters:
Amyloid and Transplanted Islets
Rickels M. R., Collins H. W., Naji A., Westermark G. T., Korsgren O., Westermark P.
Extract |
Full Text |
PDF
N Engl J Med 2008;
359:2729-2731, Dec 18, 2008.
Correspondence
This article has been cited by other articles:
Guardado-Mendoza, R., Davalli, A. M., Chavez, A. O., Hubbard, G. B., Dick, E. J., Majluf-Cruz, A., Tene-Perez, C. E., Goldschmidt, L., Hart, J., Perego, C., Comuzzie, A. G., Tejero, M. E., Finzi, G., Placidi, C., La Rosa, S., Capella, C., Halff, G., Gastaldelli, A., DeFronzo, R. A., Folli, F.
(2009). Pancreatic islet amyloidosis, {beta}-cell apoptosis, and {alpha}-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc. Natl. Acad. Sci. USA
106: 13992-13997
[Abstract][Full Text]
Kaddis, J. S., Olack, B. J., Sowinski, J., Cravens, J., Contreras, J. L., Niland, J. C.
(2009). Human Pancreatic Islets and Diabetes Research. JAMA
301: 1580-1587
[Abstract][Full Text]
Rickels, M. R., Collins, H. W., Naji, A., Westermark, G. T., Korsgren, O., Westermark, P.
(2008). Amyloid and Transplanted Islets. NEJM
359: 2729-2731
[Full Text]
Previous
